Abstract
Voriconazole is an antifungal widely used in the treatment of invasive fungal infections, thus pharmacokinetic monitoring is highly important to achieve appropriate dosages. It has been described that patients undergoing continuous renal replacement therapy did not see plasma voriconazole concentrations altered. Two cases are presented in which subtherapeutic voriconazole plasma levels are obtained while the patients are in continuous venovenous hemodiafiltration.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
